Gesco Ag · XETR:GSC1

Gesco — Q1 2025 Earnings Presentation

14 slides from Gesco's earnings presentation, May 9, 2025

  1. Slide 1: Q1 2025 Financials Conference Call

    erence Call 5

  2. Slide 2: Q1 2025 Financials

  3. Slide 3: Group at a glance

    Group at a glance 03/31/2024 | The start to the year went as Change Incoming orders thousand € 132,087 142,293 -7.2% Sales thousand € 121,712 124,297 2.1% EBITDA thousand € 8,164 8,555 -4.6% EBIT thousand € 4,099 4,037 1.5% ROS (in %) % 3.4% 3.2% 12bp EBT thousand € 3,155 2,901 8.8% Group earnings?

  4. Slide 4: Previous year adjusted for sold divisions

    Previous year adjusted for sold divisions Foundry & Q1/2024 Steelworks AstroPlast Order Intake 142.3) 5.4) 1324 -0.7, —_ -0.5} Sales 124.3 6.2 121.7 7.0} 64 EBIT 4.0 -0.8| 4A -0.6 -12.8 ROS 3.2% 12.9% 34% -73bp|_-17.9)

  5. Slide 5: Incoming orders by quarter

    Incoming orders by quarter Incoming orders are at the previous year's level and higher than sales. Compared to the previous quarter, there was a significant increase due to the pleasingly high order intake at MAE and PGW, among other things. Incoming orders in € million 142,3 132,8 133,2 1324 1252 5

  6. Slide 6: Sales by quarter

    Sales by quarter Adjusted sales increased significantly by 6.1% compared to the previous year. There was a slight decline compared to the previous quarter. In the last quarter of 2024, several large projects were delivered by SVT, which led to a significant increase in sales. Sales in € million 428.

  7. Slide 7: Segments

    Segments The new segment structure increases transparency and focus GESCO Materials Refinement & Distribution Focus: 'Processes' Mate tion Mater lon Pickhardt & Gerlach- Doerrenberg-Gruppe Health Care & Life Science Focus: 'Products' Health Ca ° Heal AMTRION Setter-Gruppe Industrial Assets & Infrast

  8. Slide 8: Materials Refinement & Distribution

    Materials Refinement & Distribution Focus: 'Processes' Incoming orders in€ million Sales in€ mitlion EBIT iné million ROS in 66.2 64.7 60.8 56.8 58.6 57.3 3.3 2.5 24 5.7% Q12024 Q12025 Q12024 Q12025 Q12024 Q12025

  9. Slide 9: Health Care & Life Science

    Health Care & Life Science Focus: 'Products' Incoming orders in€ million Sales in€ mitlion EBIT iné million ROS in 4,0 - Q12024 Q12025 Q12024 Q12025 Q12024 Q12025 42,0 42,2 38,9 39,4

  10. Slide 10: Industrial Assets & Infrastructure

    Industrial Assets & Infrastructure Focus: 'Projects' Incoming orders in€ million Sales in€ million 36.4 30.0 22.2 16.9 Q12024 Q12025 Q12024 Q12025 EBIT iné million ROS in% 0.2 1.0% “04 9.4% a Q1 2024 Q12025 10

  11. Slide 11: Cash flow increased and debt reduced

    Cash flow increased and debt reduced Working capital Free cash flow Net debt incl. leasing 3.3 41.6 173.5 173.0 3.0 39.4 2024 Q12025 Q1 2024 Q12025 2024 Q12025 n

  12. Slide 12: Group adjusted for sold divisions

    Group adjusted for sold divisions Foundry & 2024 Steelworks AstroPlast Sales 513.8 18.7, EBITDA 36.7 -5.7| EBIT 15.2) -8.5) ROS (in %) 3.0% -45.5%| Group earnings 44 -9.0) 2

  13. Slide 13: Forecast 2025

    Forecast 2025 Foundry & Deconsoli- 2024 2024 Steelworks AstroPlast dation adjusted Sales 513.8 18. 15.0) 480.1 485-515) (Group earnings 44 ‘ad on 1 13.1 tet

  14. Slide 14: Q&A

    Q&A

Gesco — Q1 2025 Earnings Presentation on 6ix